Jane Street’s Direxion Daily S&P Biotech Bear 1X Shares LABS Stock Holding History

Jane Street’s Portfolio LABS Stock Details LABS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-8,649	Closed	-$246K	–	5543
2017 Q2	$246K	Buy	8,649 +2,230	+35%	+$69.4K	﹤0.01%	3815
2017 Q1	$210K	Sell	6,419 -699	-10%	-$24.1K	﹤0.01%	3824
2016 Q4	$273K	Buy	+7,118	New	+$277K	﹤0.01%	3461
2016 Q3	–	Sell	-5,608	Closed	-$264K	–	5027
2016 Q2	$264K	Sell	5,608 -9,475	-63%	-$450K	﹤0.01%	3468
2016 Q1	$797K	Buy	+15,083	New	+$809K	﹤0.01%	2080

Jane Street's LABS Position: Q3 2017 in Review

Jane Street sold out of Direxion Daily S&P Biotech Bear 1X Shares (LABS) in Q3 2017, closing a stake of 8,649 shares — an estimated $246K sold.

Jane Street first reported a position in LABS in Q1 2016 and held it in 5 quarters. The position peaked at $797K in Q1 2016. 0 funds tracked by Wall St. Rank hold LABS as of Q3 2017.

Jane Street reported no remaining Direxion Daily S&P Biotech Bear 1X Shares position as of Q3 2017 after selling out during the quarter.
Jane Street sold 8,649 Direxion Daily S&P Biotech Bear 1X Shares shares in Q3 2017, an estimated $246K.
Jane Street first reported a position in Direxion Daily S&P Biotech Bear 1X Shares in Q1 2016 and held it in 5 quarters.
Jane Street's Direxion Daily S&P Biotech Bear 1X Shares position peaked at $797K in Q1 2016.
0 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 1X Shares as of Q3 2017.

Based on Jane Street's 13F filing for Q3 2017, filed 14 Nov 2017.